ANGIOTENSIN II
April 18, 2008
Hypertension Vaccine Could Become Reality
A vaccine being developed in Switzerland and currently in an industry-sponsored phase II trial appears to effectively block angiotensin II, a known cause of hypertension.
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.